Sectors

Today, 1.3 million people die each year because of antimicrobial resistance, a figure that could increase to 10 million by 2050 — Strathclyde’s Microplate Dx hopes to prevent that.

What's going to happen to healthcare startup funding this year? Will the IPO market recover? And what kinds of technologies are on the up? We asked some leading CVCs for their view.

The $275m round, the largest series B for three months, featured several pharmaceutical companies and is part of a thriving environment for gene therapy startups.

With a fresh cash injection from Raytheon’s RTX Ventures, EpiSci is creating autonomous software to enhance warfighters’ capabilities.

After both serving three years as Jump Capital’s vice-presidents, Saaya Nath and Tarun Gupta have been promoted to the firm’s partners.

Maria Emilie Danø Hoffman has become the energy company’s director and head of global ventures and open innovation.

Sustainability and customer experience are on the agenda for transportation CVCs in 2023.

Aleks Engel, a Novo partner and Repair Impact Fund director, will work with the firm’s bioindustrial team to accelerate sustainability.

Venture capital has poured into the cleantech sector over the past couple of years. Concerns are growing that startups may not be able to scale into viable companies that generate expected returns.

Take time, focus on quality and internal relationships, make an impact — these are the top resolutions investors have for 2023.

2022 saw a screeching turnaround in market sentiment. How well did corporate investors cope?